Johannes F E Mann Selected Research

Avosentan

3/2014	Predictors of congestive heart failure after treatment with an endothelin receptor antagonist.
3/2010	Avosentan for overt diabetic nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johannes F E Mann Research Topics

Disease

33	Type 2 Diabetes Mellitus (MODY) 06/2022 - 11/2003
24	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2002
23	Chronic Renal Insufficiency 06/2022 - 04/2002
18	Albuminuria 06/2022 - 03/2003
16	Proteinuria 10/2020 - 03/2003
15	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 11/2003
13	Stroke (Strokes) 01/2022 - 07/2005
13	Heart Failure 01/2022 - 03/2003
12	Myocardial Infarction 01/2022 - 07/2005
12	Renal Insufficiency (Renal Failure) 01/2021 - 01/2000
9	Vascular Diseases (Vascular Disease) 01/2021 - 03/2003
6	Kidney Diseases (Kidney Disease) 01/2022 - 02/2006
6	Hypertension (High Blood Pressure) 01/2021 - 01/2002
5	Hyperkalemia 12/2014 - 01/2002
4	Acute Kidney Injury (Acute Renal Failure) 01/2017 - 01/2002
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017 - 07/2009
3	Body Weight (Weight, Body) 01/2022 - 03/2014
3	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 01/2020
3	Hemorrhage 10/2012 - 04/2007
2	Disease Progression 06/2022 - 02/2006
2	Pancreatitis 01/2016 - 11/2014
2	Insulin Resistance 05/2003 - 01/2002
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2020
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2018
1	Prediabetic State (Prediabetes) 01/2018
1	Death (Near-Death Experience) 01/2016
1	Hyperphosphatemia 06/2015
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2015
1	Shock 01/2015
1	Capillary Leak Syndrome 01/2015
1	Hypothyroidism 01/2015
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2015
1	Hypovolemia 01/2015

Drug/Important Bio-Agent (IBA)

30	CreatinineIBA 01/2022 - 01/2002
19	Ramipril (Altace)FDA LinkGeneric 01/2022 - 01/2002
16	Telmisartan (Micardis)FDA Link 01/2022 - 08/2008
15	Liraglutide FDA Link 01/2022 - 11/2013
13	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2015 - 01/2002
8	AlbuminsIBA 01/2022 - 02/2004
8	Angiotensin Receptor AntagonistsIBA 04/2015 - 09/2004
5	SodiumIBA 01/2020 - 10/2013
4	LDL CholesterolIBA 01/2022 - 01/2004
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 03/2004
4	Proteins (Proteins, Gene)FDA Link 12/2015 - 01/2008
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2013 - 02/2004
4	Lipoprotein(a)IBA 02/2006 - 01/2000
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 02/2006
3	dapagliflozinIBA 01/2022 - 10/2020
3	semaglutideIBA 01/2022 - 11/2020
3	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 12/2018
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2021
3	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2020 - 01/2016
3	omega-Chloroacetophenone (Mace)IBA 01/2020 - 01/2008
3	Insulin (Novolin)FDA Link 01/2020 - 11/2013
3	Insulin Glargine (Lantus)FDA Link 01/2018 - 07/2014
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 07/2015
3	Atorvastatin (Lipitor)FDA Link 01/2016 - 01/2004
3	Pharmaceutical PreparationsIBA 11/2013 - 07/2005
3	HomocysteineIBA 02/2008 - 01/2002
2	PotassiumIBA 01/2022 - 12/2014
2	HDL CholesterolIBA 01/2022 - 01/2004
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 01/2020
2	Dietary SodiumIBA 01/2020 - 12/2016
2	Phosphates (Orthophosphate)IBA 06/2015 - 09/2007
2	Glucose (Dextrose)FDA LinkGeneric 04/2015 - 07/2014
2	Endothelin Receptor AntagonistsIBA 03/2014 - 03/2010
2	AvosentanIBA 03/2014 - 03/2010
2	Hypoglycemic Agents (Hypoglycemics)IBA 11/2013 - 02/2004
2	Clopidogrel (Plavix)FDA Link 01/2008 - 04/2007
2	apolipoprotein A-IV (apolipoprotein AIV)IBA 02/2006 - 02/2002
2	Triglycerides (Triacylglycerol)IBA 02/2006 - 01/2004
2	Arginine (L-Arginine)FDA Link 05/2003 - 01/2002
1	finerenoneIBA 06/2022
1	empagliflozinIBA 06/2022
1	HDL LipoproteinsIBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	IncretinsIBA 01/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021
1	LinagliptinIBA 01/2020
1	SaltsIBA 01/2020
1	Blood Proteins (Serum Proteins)IBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	Prednisolone (Predate)FDA LinkGeneric 01/2018
1	Azathioprine (Imuran)FDA LinkGeneric 01/2018
1	sucroferric oxyhydroxideIBA 06/2015
1	Phosphorus (Red Phosphorus)IBA 06/2015
1	TabletsIBA 06/2015
1	Sevelamer (RenaGel)FDA Link 06/2015
1	Hormones (Hormone)IBA 01/2015
1	GlobulinsIBA 01/2015

Therapy/Procedure

11	Therapeutics 06/2022 - 01/2008
4	Renal Dialysis (Hemodialysis) 01/2016 - 01/2004
2	Aftercare (After-Treatment) 01/2021 - 03/2014
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021 - 02/2006
2	Percutaneous Coronary Intervention 11/2009 - 01/2008
1	Continuous Renal Replacement Therapy 01/2021
1	Secondary Prevention 01/2021
1	Diet Therapy (Therapy, Diet) 07/2016
1	Peritoneal Dialysis 06/2015